KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 19 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,329 | -6.8% | 21,494 | 0.0% | 1.07% | -17.3% |
| Q2 2023 | $14,296 | -1.6% | 21,494 | +14.7% | 1.29% | +5.9% |
| Q1 2023 | $14,531 | +45.9% | 18,744 | +42.8% | 1.22% | +67.4% |
| Q4 2022 | $9,961 | -99.9% | 13,126 | 0.0% | 0.73% | +1.2% |
| Q3 2022 | $10,700,000 | +110.7% | 13,126 | +87.5% | 0.72% | +98.3% |
| Q2 2022 | $5,079,000 | -63.5% | 7,000 | -58.1% | 0.36% | -59.9% |
| Q1 2022 | $13,919,000 | +5.2% | 16,700 | 0.0% | 0.90% | -12.3% |
| Q4 2021 | $13,227,000 | +38.4% | 16,700 | +31.5% | 1.03% | +5.7% |
| Q3 2021 | $9,558,000 | -26.7% | 12,700 | -2.3% | 0.98% | -19.2% |
| Q2 2021 | $13,039,000 | +19.8% | 13,000 | +23.8% | 1.21% | +13.2% |
| Q1 2021 | $10,883,000 | – | 10,500 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 20,000,000 | $25,176,000 | 1.70% |
| DeepCurrents Investment Group LLC | 22,530,000 | $28,226,000 | 0.74% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $24,888,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 35,000,000 | $43,527,000 | 0.26% |
| AQR Arbitrage LLC | 4,100,000 | $5,164,000 | 0.18% |
| CSS LLC/IL | 3,000,000 | $3,781,000 | 0.14% |
| Verition Fund Management LLC | 6,579,000 | $8,286,000 | 0.07% |
| LAZARD ASSET MANAGEMENT LLC | 16,500,000 | $20,780,000 | 0.03% |
| Citadel Advisors | 43,300,000 | $54,252,000 | 0.01% |
| CREDIT SUISSE AG/ | 5,017,000 | $6,243,000 | 0.00% |